Accolade price target lowered to $15 from $17 at Stifel

Stifel lowered the firm’s price target on Accolade to $15 from $17 and keeps a Buy rating on the shares ahead of the company reporting fiscal Q3 results after the close on Monday, January 8. Accolade shares “drafted off the late year small-cap rally,” which increases risk and volatility into the Q3 report, says the analyst, who continues to like the stock on any sustained weakness.